Health
Nanoparticles elicit neutralizing antibodies to diverse SARS-CoV-2 variants – News-Medical.net
Spike-protein-based nanoparticle vaccine candidates were retained longer in follicular dendritic cells and showed higher germinal center reactions in lymph node…
Spike-protein-based nanoparticle vaccine candidates were retained longer in follicular dendritic cells and showed higher germinal center reactions in lymph node follicles compared to soluble spike protein vaccine.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected hundreds of millions worldwide since its emergence more than a year ago. The virus has also been mutating throughout the pandemic, with several new variants, likely more infectious, being reported over the last…
-
Noosa News16 hours agoPrincess Anne is coming to Australia. Here’s what we know of her plans
-
General5 hours agoCommunity devastated after freight train kills one-year-old girl near Narrabri
-
General21 hours agoPolish woman found guilty of harassing Maddie McCann’s parents, but acquitted for stalking
-
General19 hours agoTravellers face cancelled flights over US shutdown